跳至主要内容
临床试验/DRKS00006742
DRKS00006742已完成未知

Pilot study regarding the influence of bioactive enriched food on markers of the metabolic syndrome. - PATHWAY-27

Max Rubner-InstitutBundesforschungsinstitut für Ernährung und Lebensmittel0 个研究点目标入组 68 人开始时间: 2015年6月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • MS is defined when three of the following criteria are met:
  • - elevated waist circumference (men = 102 cm; women = 88 cm)
  • - elevated fasting triglycerides (= 150 mg/dL)
  • - reduced fasting HDL-cholesterol (men = 40 mg/dL; women = 50 mg/dL)
  • - elevated blood pressure (systolic = 130 mmHg and/or diastolic = 85 mmHg) or
  • hypotensive treatment
  • - elevated fasting glucose (= 110 mg/dL)
  • Subjects will be eligible to the pilot study if they are considered at risk of MS, i.e. if they
  • present two to four of the MS criteria, at least one of them being alterated of fasting
  • triglycerides or HDL-Cholesterol”.

排除标准

  • Participants that meet more than four of the metabolic syndrome criteria; -regular drug therapy with impact on serum lipids (e.g. statins, fibrates, ...);
  • - diabetes (fasting glucose = 1.26 g/L, or anti-diabetic treatment);
  • - celiac disease, lactose intolerance, allergy to milk or egg proteins;
  • - antibiotic treatment within the last 3 months;
  • - recent history of cancer or cancer treatment (less than 2 years);
  • - active or recently diagnosed intestinal malabsorption;
  • - familial dyslipidemia;
  • - illegal drug use or chronic alcoholism or active smoking (= 5 cigarettes/day);
  • - intensive physical exercise (= 5 hour/week);
  • - consumption of nutritional supplements containing DHA, BG or AC;
  • - history of allergy or intolerance to any components used in BEFs;
  • institutionalised patients, those who lack autonomy to consent or are unable to meet all
  • examinations;
  • - women who are pregnant, lactating, on contraceptive treatment or hormone replacement
  • - participation in other clinical trials that may impact on outcome;
  • - subjects deprived of their liberty by judicial or administrative decision; -Participants that are expected to be non-compliant.

研究者

发起方
Max Rubner-InstitutBundesforschungsinstitut für Ernährung und Lebensmittel

相似试验